News
Serious Fraud Office launches criminal inquiry into GlaxoSmithKline
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3612 (Published 29 May 2014) Cite this as: BMJ 2014;348:g3612- Adrian O’Dowd
- 1London
The United Kingdom’s major fraud body has launched a criminal investigation into the drug company GlaxoSmithKline (GSK). The Serious Fraud Office inquiry, announced on 27 May, will focus on the commercial practices of GSK and its subsidiaries and comes just weeks after the company was accused of bribery in China.1
The BMJ understands that the new investigation will look at …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.